Psoriasis vulgaris that respond inadequately to existing therapies.
Precautions related to INDICATIONS: Administer to any of the following patients: Patients who responded inadequately to phototherapies or other existing systemic therapies (except biologics) and who have skin eruptions over 10% or more of the body surface area.
Patients who have intractable skin eruptions.